
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+15
Delpharm is a leading CDMO : - 19 plants in France, Italy, Canada, Poland and The Netherlands - Over 1,1 billion euros turnover - 6,500 people working in the company - Most dosage forms produced For over 35 years, Delpharm has built up its position by acquiring manufacturing plants over the years, in particular from big pharmaceutical companies. As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules. Delpharm also offers full development services for...
Cmo,pharmaceutical drug,solid form,liquid form,semi solid form,cdmo,hormone,oncology,sterile,serializatiuon,serialisation,fabrication medicament,fda,pmda,anvisa,drug manufacturing,drug plant,drug development,softgel,and regulatory
Delpharm operates in the Pharmaceutical manufacturing industry.
Delpharm's revenue is 101m - 500m
Delpharm has 1001 - 5000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.